diphosphoric acid has been researched along with Sclerosis, Systemic in 1 studies
diphosphoric acid : An acyclic phosphorus acid anhydride obtained by condensation of two molecules of phosphoric acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Calcinosis was frequently detected (40% of US and 46% of the Hungarian cohort)." | 1.72 | Inorganic pyrophosphate is reduced in patients with systemic sclerosis. ( Aren, K; Bálint, L; Bocskai, M; Carns, M; Goldberg, I; Hsu, VM; Kovács, L; Kozák, E; Li, Q; McClure, ST; Rosenthal, A; Schlesinger, N; Szamosi, S; Szücs, G; Váradi, A; Varga, J, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsu, VM | 1 |
| Kozák, E | 1 |
| Li, Q | 1 |
| Bocskai, M | 1 |
| Schlesinger, N | 1 |
| Rosenthal, A | 1 |
| McClure, ST | 1 |
| Kovács, L | 1 |
| Bálint, L | 1 |
| Szamosi, S | 1 |
| Szücs, G | 1 |
| Carns, M | 1 |
| Aren, K | 1 |
| Goldberg, I | 1 |
| Váradi, A | 1 |
| Varga, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Orally Administered Pyrophosphate on Calcinosis Formation in Systematic Sclerosis[NCT04966416] | 60 participants (Anticipated) | Interventional | 2023-08-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for diphosphoric acid and Sclerosis, Systemic
| Article | Year |
|---|---|
Inorganic pyrophosphate is reduced in patients with systemic sclerosis.
Topics: Adult; Aged; Calcinosis; Diphosphates; Female; Humans; Male; Middle Aged; Scleroderma, Systemic | 2022 |